Miki De Palma graduated in Biology (1999) at the University of Torino, Italy, with a master thesis on the antiproliferative activities of type-I interferons in cancer cells. In 2004, he obtained a PhD Degree in Cell Biotechnologies from the University of Torino Medical School, where he studied the contribution of bone marrow-derived cells to tumor angiogenesis under the direction of gene therapy pioneer, Dr. Luigi Naldini. He performed his post-doctoral training at the Telethon Institute for Gene Therapy (TIGET) in Milan, to further characterize the pro-angiogenic functions of tumor-associated macrophages and develop gene transfer strategies for reprogramming them into anti-tumoral immune cells. In 2008, he was appointed group leader (with tenure since 2011) at the San Raffaele Scientific Institute, Milan, and joined the ISREC Institute, at the EPFL School of Life Sciences, in 2012. He teaches cancer biology at EPFL and serves on the editorial/advisory boards of Science Translational Medicine (AAAS), Cell Reports (Cell press), BBA-Reviews on Cancer (section editor), Cancer Immunology Research (AACR), and Carcinogenesis. In his spare time, he enjoys travelling to sub-saharan Africa and writing boring articles and books on the taxonomy of the African fruit and flower chafers. Miki received two ERC grants, in 2009 and 2016.